Roche (OTCMKTS:RHHBY) Sees Unusually-High Trading Volume – Here’s What Happened
by Scott Moore · The Cerbat GemShares of Roche Holding AG (OTCMKTS:RHHBY – Get Free Report) saw unusually-high trading volume on Thursday . Approximately 4,983,031 shares traded hands during trading, an increase of 123% from the previous session’s volume of 2,235,225 shares.The stock last traded at $53.16 and had previously closed at $53.08.
Wall Street Analyst Weigh In
A number of research analysts recently commented on RHHBY shares. JPMorgan Chase & Co. raised shares of Roche from an “underweight” rating to a “neutral” rating in a research note on Monday, December 8th. Zacks Research raised Roche from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. HSBC reaffirmed a “buy” rating and issued a $57.00 price target on shares of Roche in a research note on Wednesday, December 10th. Hsbc Global Res upgraded Roche from a “hold” rating to a “strong-buy” rating in a research note on Thursday, October 2nd. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Roche from a “sell” rating to a “hold” rating in a research note on Tuesday, November 11th. Three investment analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Roche currently has a consensus rating of “Moderate Buy” and an average target price of $57.00.
Check Out Our Latest Research Report on Roche
Roche Trading Up 1.2%
The business’s 50 day simple moving average is $48.68 and its 200-day simple moving average is $43.88. The company has a quick ratio of 1.02, a current ratio of 1.29 and a debt-to-equity ratio of 0.80.
Institutional Investors Weigh In On Roche
A number of hedge funds have recently modified their holdings of the business. Boston Common Asset Management LLC increased its stake in shares of Roche by 11.1% in the 2nd quarter. Boston Common Asset Management LLC now owns 361,833 shares of the company’s stock valued at $14,682,000 after purchasing an additional 36,101 shares during the last quarter. Sentinel Trust Co. LBA bought a new position in Roche in the third quarter valued at about $878,000. Vestmark Advisory Solutions Inc. acquired a new position in Roche during the third quarter worth about $597,000. North Star Asset Management Inc. lifted its holdings in shares of Roche by 52.0% in the second quarter. North Star Asset Management Inc. now owns 26,305 shares of the company’s stock worth $1,072,000 after acquiring an additional 9,000 shares during the last quarter. Finally, Altrius Capital Management Inc boosted its stake in shares of Roche by 4.0% in the 3rd quarter. Altrius Capital Management Inc now owns 198,278 shares of the company’s stock valued at $8,290,000 after purchasing an additional 7,659 shares in the last quarter.
About Roche
Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).
In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.